The Vivarium Foundation warned about the presence of counterfeit antivenom serum in Venezuela, a situation that, the organization warns, represents a serious danger for patients who are victims of snake bites and who depend on this treatment to survive.
According to the report released by the institution, health authorities have identified batches of antivenom without active ingredient, which prevents the toxin from being neutralized and can aggravate the consequences of poisoning.
“They may not neutralize the poison and represent a serious health risk if used as real antivenom. For this reason, the serum should always be acquired through verified, official channels with guaranteed traceability,” the organization emphasized.
The document places this complaint within a larger problem, the snake accident continues to be a significant public health challenge. in Latin America. Although Venezuela has national production of antivenom serum with scientific support, timely access to treatment and its correct administration continue to be determining factors in reducing mortality.
Exclusive manufacture of antivenom requires scientific infrastructure and rigorous protocols
The manufacture of antivenom in the country is concentrated exclusively in Biotecfar, an organization attached to the Central University of Venezuela (UCV). According to the Vivarium Foundation, it is a specialized process that requires advanced scientific infrastructure and strict production protocols.
“Manufacturing is complex, expensive and requires long processes, as well as availability of specific venom to immunize antibody-producing animals. Therefore, these products are not manufactured in common commercial laboratories,” he details.
The report also warns of frequent errors in the management of treatment. The organization emphasizes that antivenom serum should be administered only in hospital centers, due to the risk of severe adverse reactions such as anaphylaxis, and clarifies a clinical procedure that is often applied incorrectly.
“The initial dose should not be divided into separate applications. Neutralization of the venom must be timely and sufficient. Partial administrations can delay complete neutralization and favor the progression of systemic damage.”
As part of its recommendations, the Vivarium Foundation insists on strengthening prevention and planning in communities exposed to ophidic accidents. Among the suggested measures are previously locating health centers with availability of the serum, guaranteeing the cold chain of the product to maintain its effectiveness and avoiding home remedies or practices that delay specialized medical care.
